Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Obstetrics and Gynecology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
World Health Organization. Available at: http://www.who.int/mediacentre/factsheets/fs362/en/. Accessed December 15, 2017.
- Evidence for cognitive aging in midlife women: Study of Women’s Health Across the Nation.PLoS One. 2017; 12: e0169008
- Estrogen regulation of glucose metabolism and mitochondrial function: therapeutic implications for prevention of Alzheimer’s disease.Adv Drug Deliv Rev. 2008; 60: 1504-1511
- Invited review: estrogens effects on the brain: multiple sites and molecular mechanisms.J Appl Physiol (1985). 2001; 91: 2785-2801
- Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system.J Comp Neurol. 1997; 388: 507-525
- ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury.J Neurosci. 2002; 22: 8391-8401
- Estrogen receptor messenger RNA expression in rat hypothalamus as a function of genetic sex and estrogen dose.Endocrinology. 1991; 129: 3180-3186
- Regulation of estrogen receptor beta mRNA in the brain: opposite effects of 17beta-estradiol and the phytoestrogen, coumestrol.Brain Res Mol Brain Res. 1999; 67: 165-171
- Estrogen effects on cognitive and synaptic health over the lifecourse.Physiol Rev. 2015; 95: 785-807
- Estrogen binding and estrogen receptor characterization (ERα and ERβ) in the cholinergic neurons of the rat basal forebrain.Neuroscience. 2000; 96: 41-49
- Role of estrogen receptor alpha and beta expression and signaling on cognitive function during aging.Hippocampus. 2012; 22: 656-669
- Role of estrogen receptor α and β in preserving hippocampal function during aging.J Neurosci. 2013; 33: 2671-2683
- Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications.Annu Rev Pharmacol Toxicol. 2001; 41: 569-591
- The estrogen/neurotrophin connection during neural development: is co-localization of estrogen receptors with the neurotrophins and their receptors biologically relevant?.Dev Neurosci. 1996; 18: 36-48
- Estrogen increases the number of spinophilin-immunoreactive spines in the hippocampus of young and aged female rhesus monkeys.J Comp Neurol. 2003; 465: 540-550
- Dendritic growth and spine formation in response to estrogen in the developing Purkinje cell.Endocrinology. 2003; 144: 4466-4477
- Estrogen effects on the hippocampus and frontal lobes.Int J Fertil Womens Med. 2005; 50: 67-71
- Estrogen replacement increases spinophilin-immunoreactive spine number in the prefrontal cortex of female rhesus monkeys.Cereb Cortex. 2004; 14: 215-223
- Influence of different estrogens on neuroplasticity and cognition in the hippocampus.Biochim Biophys Acta. 2010; 1800: 1056-1067
- Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat.J Comp Neurol. 1993; 336: 293-306
- Estrogen and neural plasticity.Curr Dir Psychol Sci. 2000; 9: 148-152
- The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging and the Alzheimer’s Association workgroup.Alzheimers Dement. 2011; 7: 263-269
- Estradiol prevents neural tau hyperphosphorylation characteristic of Alzheimer’s disease.Ann N Y Acad Sci. 2005; 1052: 210-224
- Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer’s disease animal model.Proc Natl Acad Sci U S A. 2005; 102: 19198-19203
- Estrogen and raloxifene activities on amyloid-beta-induced inflammatory reaction.Microvasc Res. 2001; 61: 28-39
- Estradiol in vivo regulation of brain mitochondrial proteome.J Neurosci. 2007; 27: 14069-14077
- Estrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer’s disease.Adv Pharmacol. 2012; 64: 327-371
- Critical window hypothesis of hormone therapy and cognition: a scientific update on clinical studies.Menopause. 2013; 20: 695-709
- Cerebral ketone body metabolism.J Inherit Metab Dis. 2005; 28: 109-121
- The mitochondrial secret(ase) of Alzheimer’s disease.J Alzheimers Dis. 2010; 20: S381-S400
- White matter integrity and cortical metabolic associations in aging and dementia.Alzheimers Dement. 2010; 6: 54-62
- Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease.Neurology. 2007; 68: 13-19
- Estrogen: a master regulator of bioenergetic systems in the brain and body.Front Neuroendocrinol. 2014; 35: 8-30
- Brain insulin signaling and Alzheimer’s disease: current evidence and future directions.Mol Neurobiol. 2012; 46: 4-10
- Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury.Proc Natl Acad Sci U S A. 2001; 98: 1952-1957
- Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons.J Neurochem. 1996; 66: 1836-1844
- Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer’s disease.J Neurochem. 1999; 72: 1552-1563
- Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases.Nature. 2006; 443: 787-795
- Aging, gender and APOE isotype modulate metabolism of Alzheimer’s Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.J Neurochem. 2004; 90: 1011-1018
- Mitochondria as therapeutic targets of estrogen action in the central nervous system.Curr Drug Targets CNS Neurol Disord. 2004; 3: 297-313
- Midlife women's attributions about perceived memory changes: observations from the Seattle Midlife Women's Health Study.J Womens Health Gend Based Med. 2001; 10: 351-362
- A longitudinal study of cognition change during early menopausal transition in a rural community.Maturitas. 2006; 53: 447-453
- Effects of the menopause transition and hormone use on cognitive performance in midlife women.Neurology. 2009; 72: 1850-1857
- Perimenopause and cognition.Obstet Gynecol Clin North Am. 2011; 38: 519-535
- SWAN: a multicenter, multiethnic, community-based cohort study of women and the menopausal transition.in: Lobo R.A. Kelsey J. Marcus R. Menopause biology and pathobiology. Academic Press, San Diego (CA)2000: 175-188
- Trajectory clustering of estradiol and follicle-stimulating hormone during the menopausal transition among women in the Study of Women's Health across the Nation (SWAN).J Clin Endocrinol Metab. 2012; 97: 2872-2880
- Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial.JAMA. 2002; 288: 321-333
- Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women’s Health Initiative Memory Study: a randomized controlled trial.JAMA. 2003; 289: 2651-2662
- Postmenopausal hormone therapy and cognitive outcomes: the Women’s Health Initiative Memory Study (WHIMS).J Steroid Biochem Mol Biol. 2010; 118: 304-310
- Postmenopausal hormone therapy and subclinical cerebrovascular disease: the WHIMS-MRI Study.Neurology. 2009; 72: 125-134
- Conjugated equine estrogens and global cognitive function in postmenopausal women: Women’s Health Initiative Memory Study.JAMA. 2004; 291: 2959-2968
- Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI Study.Neurology. 2009; 72: 135-142
- Postmenopausal hormone therapy and cognition.Horm Behav. 2015; 74: 167-172
- Effects of conjugated equine estrogens on cognition and affect in postmenopausal women with prior hysterectomy.J Clin Endocrinol Metab. 2009; 94: 4152-4161
- Effects of combination estrogen plus progestin hormone treatment on cognition and affect.J Clin Endocrinol Metab. 2006; 91: 1802-1810
- Cognitive function in nondemented older women who took estrogen after menopause.Neurology. 1998; 50: 368-373
- Cognitive performance in surgically menopausal women on estrogen.Neurology. 2000; 55: 872-874
- Early postmenopausal hormone therapy may prevent cognitive impairment later in life.Menopause. 2005; 12: 12-17
- Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study.Menopause. 2006; 13: 28-36
- Estrogen replacement therapy and cognitive decline in older community women.J Am Geriatr Soc. 1999; 47: 518-523
- Hormone replacement therapy and incidence of Alzheimer disease in older women - the Cache County Study.JAMA. 2002; 288: 2123-2129
- Long term effects on cognitive function of postmenopausal hormone therapy prescribed to women aged 50-55 years.JAMA Intern Med. 2013; 235: 649-657
- Estrogen and cognition: applying preclinical findings to clinical perspectives.J Neurosci Res. 2003; 74: 637-643
- Estrogen therapy: is time of initiation critical for neuroprotection?.Nat Rev Endocrinol. 2009; 5: 620-627
- C terminus of Hsc70-interacting protein (CHIP)-mediated degradation of hippocampal estrogen receptor-alpha and the critical period hypothesis of estrogen neuroprotection.Proc Natl Acad Sci U S A. 2011; 108: E617-E624
- Early postmenopausal transdermal 17β-estradiol therapy and amyloid-β deposition.J Alzheimers Dis. 2016; 53: 547-556
- Effects of hormone therapy on brain structure.Neurology. 2016; 87: 887-896
- Postmenopausal hormone therapy, timing of initiation, APOE and cognitive decline.Neurobiol Aging. 2012; 33: 1129-1137
- Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial.Neurology. 2007; 69: 1322-1330
- Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling.Proc Natl Acad Sci U S A. 2003; 100: 10506-10511
- Effect of reproductive history and exogenous hormone use on cognitive function in mid- and late life.J Am Geriatr Soc. 2016; 64: 2448-2456
- Impact of type 2 diabetes and postmenopausal hormone therapy on incidence of cognitive impairment in older women.Diabetes Care. 2015; 38: 2316-2324
- Rationale and design of the Kronos Early Estrogen Prevention Study (KEEPS) and the KEEPS cognitive and affective sub study (KEEPS Cog).Brain Res. 2013; 1514: 12-17
- Effects of hormone therapy on cognition and mood in recently postmenopausal women: findings from the randomized, controlled KEEPS-cognitive and affective study.PLoS Med. 2015; 12: 1-26
- Gonadal hormones and cognitive aging: a midlife perspective.Womens Health (Lond). 2011; 7: 81-93
- Menopause-associated symptoms and cognitive performance: results from the Study of Women’s Health Across the Nation.Am J Epidemiol. 2010; 171: 1214-1224
- Pharmacogenomics of estrogens on changes in carotid artery intima-medial thickness and coronary arterial calcification: Kronos Early Estrogen Prevention Study.Physiol Genomics. 2016; 48: 33-41
- Efficacy of transdermal estradiol and micronized progesterone in the prevention of depressive symptoms in the menopause transition: a randomized clinical trial.JAMA Psychiatry. 2018; https://doi.org/10.1001/jamapsychiatry.2017.3998
- Hormone therapy in menopause: an update on cardiovascular disease considerations.Trends Cardiovasc Med. 2015; 25: 540-549
- Uterine and vaginal effects of unopposed ultralow-dose transdermal estradiol.Obstet Gynecol. 2005; 105: 779-787
- Optimal tolerability of ultra-low-dose continuous combined 17beta-estradiol and norethisterone acetate: laboratory and safety results.Climacteric. 2010; 13: 34-44
- The effects of oestrogens and their receptors on cardiometabolic health.Nat Rev Endocrinol. 2017; 13: 352-364
- Sex modifies the APOE-related risk of developing Alzheimer disease.Ann Neurol. 2014; 75: 563-573
- Apolipoprotein E, gender, and Alzheimer’s disease: an overlooked, but potent and promising interaction.Brain Imaging Behav. 2014; 8: 262-273
Article info
Footnotes
Disclosure Statement: No disclosures.
Funding: KEEPS Continuation Grant number: NIH-NIA 1RF1AG057547; GRECC article number: 002 to 2018 (C. Gleason). The Study of Women's Health Across the Nation (SWAN) has grant support from the National Institutes of Health (NIH), DHHS, through the National Institute on Aging (NIA), the National Institute of Nursing Research (NINR) and the NIH Office of Research on Women's Health (ORWH) (Grants U01NR004061; U01AG012505, U01AG012535, U01AG012531, U01AG012539, U01AG012546, U01AG012553, U01AG012554, U01AG012495) (C. Derby).
The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the NIA, NINR, ORWH, or the NIH.
Identification
Copyright
© 2018 Elsevier Inc. All rights reserved.
